Eden Research has completed a placing and retail offer
Eden Research plc has raised funds to build on its achievements in seed treatment, expand the markets for its existing biopesticide products, as well as invest in further developing its bioinsecticide.
Eden is the UK’s only AIM-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Oaklins Cavendish, based in the UK, acted as nominated advisor in connection with Eden Research’s recent placing.
Contacter l'équipe de la transaction
Transactions connexes
Backspin has completed a mandatory public tender offer for the shares of Spindox
Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.
En apprendre plusOmer Engineering has completed an IPO
Omer Engineering Ltd. has successfully launched its IPO on the Tel Aviv Stock Exchange, pricing shares as part of a plan to raise approximately US$94 million at an implied pre-money valuation of around US$313 million. The offering included both newly issued shares and a secondary sale by existing shareholders, who retained a significant majority stake post-IPO. This transaction underscores strong investor interest in scaling the company’s operations and enhancing its capital.
En apprendre plusEbidco has completed a voluntary public tender offer for the warrants of Eles Semiconductor Equipment
Ebidco S.r.l. has completed a voluntary public tender offer for the warrants of Eles Semiconductor Equipment S.p.A.
En apprendre plus